TIKOMED AB
TIKOMED AB is a privately owned company based in Viken, Sweden. It is governed by the Laws of the Kingdom of Sweden and was formed in accordance with the Swedish Company Act in 2002. We develop and commercialize innovative treatments for patients with severe and life-threatening conditions. Our drugs have the potential to improve outcomes in the treatment of neurological and opthalmic disease and for ground-breaking regenerative cell therapies. They give hope for patients lacking satisfactory alternatives.
Company details
Find locations served, office locations
- Business Type:
- Technology
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Internationally (various countries)
About Us
We combine independent expertise in drug development with extensive business and scientific experience to navigate the complex pathway from lab to commercialisation. Our desire to drive scientific innovation is founded on a patient-centric vision, a clear business strategy, comprehensive product protection, and strong development partnerships. Our open information policy keeps our partners informed of our achievements while respecting the need for confidentiality.
We work hard to identify and develop drugs with the potential to satisfy the unmet need for disease modifying therapies. TIKOMED AB is an investment/holding company that develops projects through daughter companies. We identify and develop molecules for clinical trial then exit projects through a partnering deal or trade sale to biopharmas capable of progressing the drug to market.